Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $811.2M | $929.6M | $991.5M | $240M | $250.3M | |
| Gross Profit | $290.2M | $363.1M | $387.4M | $90.9M | $102.1M | |
| Operating Income | $218.7M | $292.2M | $318.6M | $75.6M | $85.4M | |
| EBITDA | $462.2M | $550.4M | $600M | $142.8M | $156.6M | |
| Diluted EPS | $0.15 | $0.55 | $0.80 | $0.13 | $0.26 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $198.9M | $180.1M | $223.7M | $262.4M | $251.6M | |
| Total Assets | $2.8B | $2.7B | $2.7B | $2.8B | $2.7B | |
| Current Liabilities | $167.5M | $158.1M | $177.7M | $183.1M | $184.8M | |
| Total Liabilities | $2.2B | $2.3B | $2.5B | $2.7B | $2.7B | |
| Total Equity | $634.8M | $412.2M | $226.7M | $61.6M | -$76.8M | |
| Total Debt | $2B | $2.1B | $2.3B | $2.5B | $2.5B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $262.4M | $302.7M | $385M | $48.5M | $75.9M | |
| Cash From Investing | -$196.9M | -$254.4M | -$90.7M | -$28.4M | -$23.4M | |
| Cash From Financing | -$65.5M | -$48.3M | -$294.4M | -$20M | -$52.5M | |
| Free Cash Flow | $57.2M | $47.4M | $290.4M | $19.8M | $51.9M | |
USA Compression Partners LP engages in the provision of compression services in terms of total compression fleet horsepower. Its services include processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. The company was founded by Eric Dee Long in1998 and is headquartered in Austin, TX.
In the current month, USAC has received 0 Buy ratings 4 Hold ratings, and 0 Sell ratings. The USAC average analyst price target in the past 3 months is $26.83.
According to analysts, the consensus estimate is that USA Compression Partners LP share price will rise to $26.83 per share over the next 12 months.
Analysts are divided on their view about USA Compression Partners LP share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that USA Compression Partners LP is a Sell and believe this share price will drop from its current level to $23.00.
The price target for USA Compression Partners LP over the next 1-year time period is forecast to be $26.83 according to 4 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for USA Compression Partners LP is a Hold. 4 of 4 analysts rate the stock a Hold at this time.
You can purchase shares of USA Compression Partners LP via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase USA Compression Partners LP shares.
USA Compression Partners LP was last trading at $23.24 per share. This represents the most recent stock quote for USA Compression Partners LP. Yesterday, USA Compression Partners LP closed at $23.11 per share.
In order to purchase USA Compression Partners LP stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.